Andhra Pradesh

National Institute of Nutrition (NIN) was founded by Sir Robert McCarrison in the year 1918 as ‘Beri-Beri’ Enquiry Unit in a single room laboratory at the Pasteur Institute, Coonoor, Tamil Nadu. Within a short span of seven years, this unit blossomed into a "Deficiency Disease Enquiry" and later in 1928, emerged as full-fledged "Nutrition Research Laboratories" (NRL) with Dr.

About Authors:
M.sandhya sree*, Sowmya**
*Assistant Professor ,
Department of pharmacology,
BA&KR pharmacy college,
JNTUK, Andhra Pradesh.
**MBBS,GMC,
Guntur, Andhra Pradesh.

Abstract:
The study was conducted in two villages of Guntur district (Andra Pradesh) to determine the nature and extent of health problems of rural women. The data were collected from one hundred randomly selected rural ladies by interviewing them with the help of an interview schedule developed for  the  purpose.
The identified health problems were classified. The findings of the study indicated the prevalence of a number of health problems among rural women and a need was felt for their education on health aspects. A sizeable number of them were found to have suffered from bronchitis, coryza, indigestion, constipation, diarrhea , conjunctivitis, dandruff, tartar deposits on teeth, skin diseases, gynecological diseases and some other diseases like rheumatism, arthritis, etc.
The existence of a government hospital in village had no association of significant level with the health problems of rural women. Majority of the respondents perceived the treatment given in government hospital to be not effective and several other constraints in availing of the treatment facilities.

About Author:
Maanasa.B,
Sri Sai Aditya Pharmaceutical Sciences & Research,
Andhrapradesh

ABSTRACT:
Biomarkers in general used as an indicator of the biological response, pathological response and pharmacological responses and mostly used in scientific fields. Specifically, biomarkers indicate change in expression or the protein nature that correlate with disease progression. An ideal biomarker must be sensitive, specific and accurate and must be able to reveal the nature of disease / able to predict the outcome of the tumor reoccurrence. There are different types of biomarkers individualizing different roles like diagnostic biomarkers, detection biomarkers, prognostic biomarkers, predictive biomarkers. These biomarkers are used throughout the clinical trials process of cardiology, neurology and oncology and the present article describes the biomarkers.

National Institute of Nutrition (NIN) was founded by Sir Robert McCarrison in the year 1918 as ‘Beri-Beri’ Enquiry Unit in a single room laboratory at the Pasteur Institute, Coonoor, Tamil Nadu. Within a short span of seven years, this unit blossomed into a "Deficiency Disease Enquiry" and later in 1928, emerged as full-fledged "Nutrition Research Laboratories" (NRL) with Dr.

i3 is a full-service Clinical Research Organization (CRO) focused on five therapeutic areas: Oncology; Cardiology; The Central Nervous System; Respiratory and Infectious Diseases; and Endocrinology and Metabolic diseases. Therapeutic specialization drives all aspects of business in this global CRO - from project staffing and talent management to quality initiatives.

About Authors:
Saravana Kumar K, Ramesh Y*,  
Department of Pharmaceutics,
Seshachala College of Pharmacy,
Tirupathi – Chennai High way,  
Puttur-517 583,  Chittoor (dist),
A.P., India

Abstract
Plants and their extracts have immense potential for the management and treatment of wounds. Wound healing is complicated process that involves four phases: (i) coagulation begins immediately after injury, (ii) Inflammation which begins within hours, (iii) Proliferation which begins within days, (iv) Remodeling up to period of week, months, up to year. The phyto medicine for wound healing are not only cheap and affordable but are also purportedly safe as hypersensitive reactions are rarely encountered with the use of these agents. Mainly these crude drugs are obtained from various climatic conditions Collection, cultivating, Harvesting & Isolation of active ingredients to treat various types of diseases.

[adsense:336x280:8701650588]

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

At i3 Global, We believe in science for the sake of people—in the end, it’s about better patient care.
Because we are a service organization through and through, we’ll build a relationship to suit your specialized needs. Tell us what you need and where in the world you want us to be, and we will deliver.

About Authors:
V. Ravi Chandra
Research Associate
Parexel
B.Pharmacy from Priyadarshini College of pharmacy,
Osmania University,
Hyderabad, AP, INDIA

Abstract:
Huntington's disease is an intricate illness. It is a neurodegenerative, insidious disorder-which means it is harmful and fatal but gradually. The onset of the disease is very late to diagnose the disease. Huntington's disease (HD) also called as ‘Huntington’s Chorea’. Chorea means dance in Greek, which is aftereffect of genetically programmed degeneration of brain cells, called neurons, in certain areas of the brain. This degeneration causes uncontrolled movements, loss of intellectual faculties, and emotional disturbance. By choreic movement physically we can diagnose HD. HD is also a familial disease, passed from parent to child through a mutation in the normal gene. Attempts to study early disease are not unique in neurology (e.g., mild cognitive impairment and vascular cognitive impairment), but studying otherwise healthy-appearing individuals who have nearly 99% certainty of manifesting the symptoms of brain disease does provide distinct but valuable information about the true natural history of the disease. A genetic test, coupled with a complete medical history and neurological and laboratory tests, helps physicians diagnose HD. Presymptomic testing is available for individuals who are at risk for carrying the HD gene. HD occurs in about one out of every 10,000 Caucasian individuals. In India, the cases are unknown because of failure of doctors to diagnose HD as they never seen HD in their practice. Approximately 2.5 times more individuals are at risk for the disorder because of the midlife peak in age at onset.